Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Elizabeth Dark +44 115 969 1169
Elizabeth.Dark@nuh.nhs.uk


Mouaid Aljehani +44 115 969 1169
Mouaid.Aljehani@nottingham.ac.uk


Study Location:

Find another location


Questions to ask
Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - Asthma: Phenotyping Exacerbations 3
Back

Asthma: Phenotyping Exacerbations 3

Not Recruiting

Open to: ALL

Age: 18.0 - N/A

Nottingham

Medical Conditions

Asthma

This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


Exacerbations of asthma (asthma attacks) are very common in the UK. They are frightening for patients, expensive for the health service, and occasionally lead to avoidable deaths.

Despite the obvious importance of asthma attacks, they remain poorly understood. Although some of the triggers for attacks are known, the resultant characteristics of attacks are not. Recent research has shown different inflammation profiles associated with asthma attacks; however, this is not well understood, and all asthma attacks are treated the same. Increased knowledge about the nature of asthma attacks may better define these attacks and help develop more targeted treatment options.

This study aims to describe the characteristics of patients admitted with asthma attacks. The recovery and response to standard treatment for asthma attacks following discharge from the hospital will also be described.

This is achieved by studying the characteristics of asthma attacks in patients hospitalized with acute asthma. Participants will be asked to attend two follow-up visits during which their response to treatment will be described.

The study is planned to last for 2.5 years, with a recruitment period of 18 months, and will include 100 participants with acute asthma.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

May 2022 Dec 2023

OBSERVATIONAL

Intervention Type : DIAGNOSTIC_TEST
Intervention Description : Spirometry including peak flow to assess the degree of airway obstruction. Spirometry will be conducted according to a study SOP. The Global Lung Function (GLI) 2012 equations will be used. Reversibility testing will not be routinely performed. Thus, asthma medications will not normally be withheld for study visits and patients should take their inhalers as usual. The same type of device will be used at each visit.

Intervention Arm Group : Asthma Attack patients.;

Intervention Type : DIAGNOSTIC_TEST
Intervention Description : Fractional Exhaled Nitric Oxide (FeNO) to assess the degree of airway inflammation. FeNO will be measured using a standard device (NIOXX Vero®) in accordance with the manufacturer's guidelines. The same type of device will be used at each visit. FeNO should be performed prior to any other respiratory assessment if possible.

Intervention Arm Group : Asthma Attack patients.;

Intervention Type : DIAGNOSTIC_TEST
Intervention Description : FOT is a non-invasive method that evaluates resistance and reactance in the respiratory system during tidal breathing. It should be performed after FeNO, but prior to Spirometry and will be conducted according to a study SOP.

Intervention Arm Group : Asthma Attack patients.;

Intervention Type : PROCEDURE
Intervention Description : Sputum Induction for the assessment of airway inflammation and microbiology. Sputum induction will be performed according to an SOP, which includes measures to protect the safety of participants. These consist of pre-treatment with Salbutamol, a short acting bronchodilator, stipulated levels of lung function in order to perform the test and stopping criteria. If the participant is unable to undergo the procedure, due to safety reasons, they will be asked to produce a spontaneous sputum sample. Sputum samples will be collected for a differential cell count, bacterial culture and sensitivity and storage for future research. Procedures for sampling and processing will be detailed in a study SOP.

Intervention Arm Group : Asthma Attack patients.;

Intervention Type : DIAGNOSTIC_TEST
Intervention Description : Blood will be collected for laboratory analysis, including Vitamin D, Haematology, WCC differential, C-Reactive protein.

Intervention Arm Group : Asthma Attack patients.;

Intervention Type : DIAGNOSTIC_TEST
Intervention Description : Nasal lavage samples will be taken at the baseline (attack) visit. Samples will be obtained by injecting 5ml of sterile normal saline into the participant's nostrils via a nasal adaptor and then immediately aspirated. These will be placed in a sterile container and transported to the laboratory for viral identification. This procedure will be detailed in a study SOP.

Intervention Arm Group : Asthma Attack patients.;

Intervention Type : DIAGNOSTIC_TEST
Intervention Description : A throat swab will be taken at the baseline (attack) visit for viral identification.

Intervention Arm Group : Asthma Attack patients.;

Intervention Type : DIAGNOSTIC_TEST
Intervention Description : Nasal brushings samples may be taken at baseline (attack) and at second visits for RNA and DNA extraction. This will be optional and specific consent from participants will be sought. Procedures for sampling and processing will be detailed in a study SOP.

Intervention Arm Group : Asthma Attack patients.;

Intervention Type : DIAGNOSTIC_TEST
Intervention Description : Nasal absorption will be used to collect mucosal lining fluid from the respiratory tract for cytokines profiling at baseline (attack) and at second visits.

Intervention Arm Group : Asthma Attack patients.;

Intervention Type : OTHER
Intervention Description : Medical history will include clinically significant diseases and prior surgeries and smoking history. A specific respiratory history will also be recorded. Demographic data will include age, sex and self- reported race/ethnicity. Medication use will also be collected.

Intervention Arm Group : Asthma Attack patients.;

Intervention Type : OTHER
Intervention Description : The incidence of upper airway symptoms will be assessed using Sino-nasal Outcome Test (SNOT).

Intervention Arm Group : Asthma Attack patients.;

Intervention Type : OTHER
Intervention Description : The incidence of Gastroesophageal Reflux Disease will be assessed using GERDQ questionnaire.

Intervention Arm Group : Asthma Attack patients.;

Intervention Type : OTHER
Intervention Description : The incidence of vocal cord dysfunction will be assessed using Pittsburgh Vocal Cord Dysfunction (VCD) Index

Intervention Arm Group : Asthma Attack patients.;

Intervention Type : OTHER
Intervention Description : The incidence of dysfunctional breathing will be assessed using Nijmegen dysfunctional questionnaire.

Intervention Arm Group : Asthma Attack patients.;

Intervention Type : OTHER
Intervention Description : The incidence of anxiety and depression will be assessed using Hospital Anxiety and Depression Scale (HADS).

Intervention Arm Group : Asthma Attack patients.;

Intervention Type : OTHER
Intervention Description : In order to assess adherence as a factor in exacerbations, a participant's beliefs and attitudes towards medicines will be explored using the Medicines Adherence Report Scale (MARS) questionnaire. Non-intentional non-compliance with usual treatment will be assessed by checking inhaler technique; poor inhaler technique will be reported to the participant's clinical team. Also, GP records will be reviewed for information on medications prescribed in the last 12 months.

Intervention Arm Group : Asthma Attack patients.;

Intervention Type : OTHER
Intervention Description : The impact of acute asthma on quality of life will be assessed using Acute Asthma Quality of Life Questionnaire at baseline and follow up.

Intervention Arm Group : Asthma Attack patients.;



You can take part if:



You may not be able to take part if:


This is in the inclusion criteria above


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • Nottingham University Hospital
    Nottingham
    Nottinghamshire
    NG5 1PB

Mouaid Aljehani +44 115 969 1169
Mouaid.Aljehani@nottingham.ac.uk


Elizabeth Dark +44 115 969 1169
Elizabeth.Dark@nuh.nhs.uk



The study is sponsored by University of Nottingham



We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?
Read full details for Trial ID: NCT05446090
Last updated 30 June 2022

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.   

Back to the top